CDKN1C mutations: two sides of the same coin.

Area of Science:

• Genetics
• Developmental Biology
• Epigenetics

Background:

• The CDKN1C gene, located at 11p15.5, is a crucial negative regulator of cellular proliferation.
• Imprinted genes, including CDKN1C, play vital roles in growth regulation.
• Alterations in CDKN1C are associated with significant human growth disorders.

Purpose of the Study:

• To elucidate the role of CDKN1C mutations in growth disorders.
• To connect molecular alterations in 11p15.5 to opposite growth phenotypes.
• To deepen the understanding of CDKN1C gene function, regulation, and epigenetic mechanisms.

Main Methods:

• Analysis of CDKN1C gene mutations in patients with growth disorders.
• Functional studies investigating the impact of mutations on CDKN1C activity.
• Correlation of genetic findings with clinical phenotypes (overgrowth and growth retardation).

Main Results:

• Loss-of-function mutations in CDKN1C are associated with overgrowth disorders, such as Beckwith-Wiedemann syndrome (BWS).
• Gain-of-function mutations in the PCNA domain of CDKN1C are linked to growth-retarded conditions, including IMAGe syndrome and Silver-Russell syndrome (SRS).
• These findings establish a comprehensive spectrum of CDKN1C-related growth abnormalities.

Conclusions:

• CDKN1C mutations are definitively linked to both overgrowth and growth-retardation syndromes.
• The study bridges the understanding of molecular defects at 11p15.5 and their phenotypic outcomes.
• This research enhances comprehension of gene regulation, cellular proliferation control, and epigenetic mechanisms in development.